Cargando…

An update on the status of breast cancer screening in Brazil after the covid-19 pandemic

We have previously reported the impact of covid-19 pandemic on breast cancer screening, in Brazil: among women aged 50–69 years, mammography attendance decreased by 42% in public healthcare (SUS), comparing 2019 and 2020. In this short communication, we wish to present: a) an update of the number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessa, Jordana de Faria, Novita, Guilherme, Freitas, Ruffo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550160/
https://www.ncbi.nlm.nih.gov/pubmed/36259913
http://dx.doi.org/10.11606/s1518-8787.2022056004545
_version_ 1784805818051330048
author Bessa, Jordana de Faria
Novita, Guilherme
Freitas, Ruffo
author_facet Bessa, Jordana de Faria
Novita, Guilherme
Freitas, Ruffo
author_sort Bessa, Jordana de Faria
collection PubMed
description We have previously reported the impact of covid-19 pandemic on breast cancer screening, in Brazil: among women aged 50–69 years, mammography attendance decreased by 42% in public healthcare (SUS), comparing 2019 and 2020. In this short communication, we wish to present: a) an update of the number of mammograms performed, in 2021; b) an exploratory analysis of the characteristics of the screened population between 2019 and 2021. A total of 1.675.307 mammograms were performed in 2021, nearly 15% lower than pre-pandemic levels. Almost a third, 29.5% of them, had intervals greater than three years. In accordance with our previous study, the number of patients with palpable lumps on physical exam increased. The consequences of postponing breast cancer screening during the pandemic are still uncertain. Unfortunately, as of December 2021, screening attendance has not resumed. On the contrary, our results show an increase in the fraction of women with mammography delayed beyond three years.
format Online
Article
Text
id pubmed-9550160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Faculdade de Saúde Pública da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-95501602022-10-13 An update on the status of breast cancer screening in Brazil after the covid-19 pandemic Bessa, Jordana de Faria Novita, Guilherme Freitas, Ruffo Rev Saude Publica Brief Communication We have previously reported the impact of covid-19 pandemic on breast cancer screening, in Brazil: among women aged 50–69 years, mammography attendance decreased by 42% in public healthcare (SUS), comparing 2019 and 2020. In this short communication, we wish to present: a) an update of the number of mammograms performed, in 2021; b) an exploratory analysis of the characteristics of the screened population between 2019 and 2021. A total of 1.675.307 mammograms were performed in 2021, nearly 15% lower than pre-pandemic levels. Almost a third, 29.5% of them, had intervals greater than three years. In accordance with our previous study, the number of patients with palpable lumps on physical exam increased. The consequences of postponing breast cancer screening during the pandemic are still uncertain. Unfortunately, as of December 2021, screening attendance has not resumed. On the contrary, our results show an increase in the fraction of women with mammography delayed beyond three years. Faculdade de Saúde Pública da Universidade de São Paulo 2022-10-05 /pmc/articles/PMC9550160/ /pubmed/36259913 http://dx.doi.org/10.11606/s1518-8787.2022056004545 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Bessa, Jordana de Faria
Novita, Guilherme
Freitas, Ruffo
An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
title An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
title_full An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
title_fullStr An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
title_full_unstemmed An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
title_short An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
title_sort update on the status of breast cancer screening in brazil after the covid-19 pandemic
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550160/
https://www.ncbi.nlm.nih.gov/pubmed/36259913
http://dx.doi.org/10.11606/s1518-8787.2022056004545
work_keys_str_mv AT bessajordanadefaria anupdateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic
AT novitaguilherme anupdateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic
AT freitasruffo anupdateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic
AT bessajordanadefaria updateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic
AT novitaguilherme updateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic
AT freitasruffo updateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic